EGFR codon 497 polymorphism - Implications for receptor sensitivity to inhibitors in HNSCC cell lines

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 59-65

  Krohn, Vanessa ^a   Wiegand, Susanne ^a   Werner, Jochen A ^a   Mandic, Robert ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

AG1478; Cetuximab; EGFR; Erk 1 2; HNSCC; Polymorphism

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CODON; DNA POLYMORPHISM; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GENE SEQUENCE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CODON; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; HEAD AND NECK NEOPLASMS; HUMANS; POLYMORPHISM, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 79851502880     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wheeler DL, Dunn EF and Harari PM: Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493-507, 2010.
2. Dobrossy L: Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24: 9-17, 2005.
3. Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE and Janne PA: Differential effects of gefitinib and cetuximab on non-small cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst 97: 1185-1194, 2005. (Pubitemid 41258224)
4. Goncalves A, Esteyries S, Taylor-Smedra B, Lagarde A, Ayadi M, Monges G, Bertucci F, Esterni B, Delpero JR, Turrini O, Lelong B, Viens P, Borg JP, Birnbaum D, Olschwang S and Viret F: A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment. BMC Cancer 8: 169, 2008.
5. Bandres E, Barricarte R, Cantero C, Honorato B, Malumbres R, Zarate R, Alcalde J and Garcia-Foncillas J: Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients. Oral Oncol 43: 713-719, 2007. (Pubitemid 47058373)
6. Choura M, Frikha F, Kharrat N, Aifa S and Rebai A: Investigating the function of three non-synonymous SNPs in EGFR gene: structural modelling and association with breast cancer. Protein J 29: 50-54, 2010.
7. Jin T, Yu CX, Lei DP, Liu DY, Xu FL, Lu YT and Pan XL: Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN). Acta Otolaryngol 1-7, 2008.
8. Kallel I, Rebai M, Khabir A, Farid NR and Rebai A: Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes, EGFR and ErbB-2 protein expression, and breast cancer risk in Tunisia. J Biomed Biotechnol 2009: 753683, 2009.
9. Kaneko K, Kumekawa Y, Makino R, Nozawa H, Hirayama Y, Kogo M, Konishi K, Katagiri A, Kubota Y, Muramoto T, Kushima M, Ohmori T, Oyama T, Kagawa N, Ohtsu A and Imawari M: EGFR gene alterations as a prognostic biomarker in advanced esophageal squamous cell carcinoma. Front Biosci 15: 65-72, 2010.
10. Klinghammer K, Knodler M, Schmittel A, Budach V, Keilholz U and Tinhofer I: Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clin Cancer Res 16: 304-310, 2010.
11. Zhu J, Meng X, Yan F, Qin C, Wang M, Ding Q, Li P, Yang J, Ju X, Zhang Z, Wang S and Yin C: A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. J Hum Genet 55: 236-240, 2010.
12. Wang WS, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC, Wang HS and Su Y: Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res 13: 3597-3604, 2007.
13. Lansford C, Grenman R, Bier H, Somers KD, Kim S-Y, Whiteside TL, Clayman G and Carey TE: Head and Neck Cancers. In: Human Cell Culture Vol 2, Cancer Cell Lines Part 2. Masters J (ed.). Dordrecht (Holland), Kluwer Academic Press, pp. 185-255, 1999.
14. Mandic R, Eikelkamp N, Peldszus R, Sadowski M, Sesterhenn AM, Dunne AA and Werner JA: Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region. Anticancer Res 21: 3413-3418, 2001. (Pubitemid 34224245)
15. Mandic R, Schamberger CJ, Muller JF, Geyer M, Zhu L, Carey TE, Grenman R, Dunne AA and Werner JA: Reduced cisplatin sensitivity of head and neck squamous cell carcinoma cell lines correlates with mutations affecting the COOH-terminal nuclear localization signal of p53. Clin Cancer Res 11: 6845-6852, 2005. (Pubitemid 41428739)
16. Mandic R, Rodgarkia-Dara CJ, Zhu L, Folz BJ, Bette M, Weihe E, Neubauer A and Werner JA: Treatment of HNSCC cell lines with the EGFR-specific inhibitor cetuximab (Erbitux) results in paradox phosphorylation of tyrosine 1173 in the receptor. FEBS Lett 580: 4793-4800, 2006. (Pubitemid 44286833)
17. Loeffler-Ragg J, Witsch-Baumgartner M, Tzankov A, Hilbe W, Schwentner I, Sprinzl GM, Utermann G and Zwierzina H: Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur J Cancer 42: 109-111, 2006. (Pubitemid 41814540)
18. Lemos-Gonzalez Y, Paez de la CM, Rodriguez-Berrocal FJ, Rodriguez-Pineiro AM, Pallas E and Valverde D: Absence of activating mutations in the EGFR kinase domain in Spanish head and neck cancer patients. Tumour Biol 28: 273-279, 2007. (Pubitemid 350165833)
19. Lee JW, Soung YH, Kim SY, Nam HK, Park WS, Nam SW, Kim MS, Sun DI, Lee YS, Jang JJ, Lee JY, Yoo NJ and Lee SH: Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res 11: 2879-2882, 2005.